Welcome > Support > Reference Treatises  
 
 
E
 
Read
Writer panagene     (Date : 2011-05-16 13:57:03)
Subject [Scientific publications] [Clamp]Rapid and Sensitive Detection of KRAS Mutation by Peptide Nucleic Acid-based Real-time PCR Clamping: A Comparison with Direct Sequencing between Fresh Tissue and Formalin-fixed and Paraffin Embedded Tissue of Colorectal Cancer
Content

The Korean Journal of Pathology 2011; 45: 151-159
DOI: 10.4132/KoreanJPathol.2011.45.2.151

Rapid and Sensitive Detection of KRAS Mutation by Peptide Nucleic Acid-based Real-time PCR Clamping: A Comparison with Direct Sequencing between Fresh Tissue and Formalin-fixed and Paraffin Embedded Tissue of Colorectal Cancer


Dongjun Jeong¡¤Yujun JeongJonghyun Lee1¡¤Moo-Jun Baek2Yongbae Kim3¡¤Ji-Hye LeeHyun-Deuk Cho¡¤Mee-Hye OhChang-Jin Kim

Abstract
Background: Rapid and sensitive detection of KRAS mutation is needed to maximize the benefits for patients who are being treated with monoclonal antibodies to target the epidermal growth factor receptor in colorectal cancer. The aim of this study is to evaluate the efficacy of the peptide nucleic acid clamp real-time PCR (PCqPCR) as compared to that of direct sequencing (DS) between using fresh colorectal cancer tissue and the matched formalin-fixed and paraffin-embedded (FFPE) colorectal cancer tissue. Methods: The efficacy of PCqPCR was evaluated and compared with that of DS using fresh tissue and matched FFPE tissue from 30 cases of colorectal cancer. Results: PCqPCR is more sensitive than DS for detecting KRAS mutation. PCqPCR detected 1% of mutants in 1 ng DNA. PCqPCR detected mutation in 1% of mutant cells, while DS barely detected, by manual reading, that in 20-50% of mutant cells. In the clinical samples, PCqPCR detected KRAS mutation in 60.0% while DS detected KRAS mutation in 53.3% of the colorectal cancers. The two methods showed a 100% concordance rate for detecting KRAS mutation between the fresh tissue and FFPE tissue. Conclusions: The PCqPCR method is efficiently applicable for the detection of KRAS mutation in a clinical setting.

Keywords Sequencing; DNA; Peptide nucleic acids; Polymerase chain reaction; Colorectal neoplasms; KRAS gene


 

 No   Subject Writer File Count
   47           [Scientific publications] [2016]Comparison of EGFR .. Panagene 65535
   46           [Scientific publications] [2015]IDH Mutation Analys.. Panagene 65535
   45           [Scientific publications] [2015]Low frequency of KR.. Panagene 65535
   44           [Scientific publications] [2015]Simultaneous genoty.. Panagene 59867
   43           [Scientific publications] [2014]Simultaneous diagno.. Panagene 60063
   42           [Scientific publications] [2014]KRAS Mutation Detec.. Panagene 59908
   41           [Scientific publications] [2013]Detection of EGFR m.. Panagene 60189
   40           [Scientific publications] [2013]Detection and compa.. Panagene 60191
   39           [Scientific publications] [2013]Detection of BRAF V.. Panagene 59906
   38           [Scientific publications] [2013]Comparison of Direc.. Panagene 59908
   37           [Scientific publications] [PNAClamp]Detection of EG.. Panagene 59904
¢º           [Scientific publications] [Clamp]Rapid and Sensitiv.. panagene 60186
   35           [Scientific publications] [PNA microarray] Developm.. Panagene 59908
   34           [Scientific publications] [PANArray¢â] JHDM3A module.. Panagene 60089
   33           [Scientific publications] [PNA Chip vs DNA Chip cli.. Panagene 60659
   32           [Scientific publications] [Panagene publication] PN.. Panagene 62380
   31           [Scientific publications] [Panagene publication] PN.. panagene 60705
   30           [Scientific publications] [Panagene publication] Pe.. panagene 59917
   29           [Scientific publications] [Panagene publication] Hi.. panagene 60452
   28           [Scientific publications] [PNA]Membrane-based hybri.. Panagene 59912
 

< 1 2 3 >